A week into his tenure as head of the FDA’s Center for Drug Evaluation and Research, experts agree that Rick Pazdur is the “ideal fit” to stabilize the agency. And, according to one ex-FDA official, ...
The FDA has appointed one of its most respected cancer drug regulators to lead the agency’s main division for approving new drugs.
The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.Pazdur ...
The FDA on Tuesday announced 26-year agency veteran Richard Pazdur will replace a top regulator who resigned earlier this month amid accusations of abusing his power. Pazdur will be the director of ...
"FDA’s revolving door reveals Pazdur as new CDER head" was originally created and published by Clinical Trials Arena, a ...